Patrick Hwu


Ontology type: schema:Person     


Person Info

NAME

Patrick

SURNAME

Hwu

Publications in SciGraph latest 50 shown

  • 2018-12 RNA editing derived epitopes function as cancer antigens to elicit immune responses in NATURE COMMUNICATIONS
  • 2018-12 Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2018-02-13 Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL' in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2017-12 Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma in NPJ GENOMIC MEDICINE
  • 2017-12 Erratum to: A case report of Grover’s disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1 in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2017-12 Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes in CLINICAL SARCOMA RESEARCH
  • 2017-12 Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain in NATURE COMMUNICATIONS
  • 2017-12 HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes in NATURE COMMUNICATIONS
  • 2017-10 A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2017-09-19 Chimeric antigen receptor T-cell therapy — assessment and management of toxicities in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2017-07 CpG-based immunotherapy impairs antitumor activity of BRAF inhibitors in a B-cell-dependent manner in ONCOGENE
  • 2017-07 Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma in JOURNAL OF NEURO-ONCOLOGY
  • 2016-12 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2016-12 A case report of Grover’s disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1 in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2016-12 Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set in BMC MEDICINE
  • 2016-12 Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn’s disease: a case report in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2016-12 Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma in SCIENTIFIC REPORTS
  • 2016-11 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2016-11 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2016-07 Melanoma and immunotherapy bridge 2015 in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2016 Novel Treatments in Development for Melanoma in MELANOMA
  • 2015-12 Single-cell motility and gene expression signature as predictors of the overall survival of act in melanoma patients in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-12 Preclinical development of tumor-infiltrating lymphocyte therapy for ovarian cancer in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-12 You can run but you can't hide: tracking T cells in metastatic melanoma patients treated with tumor-infiltrating lymphocytes in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-12 Targeting the indoleamine 2,3-dioxygenase pathway in cancer in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-12 Pilot study of intratumoral (IT) cryoablation (cryo) in combination with systemic checkpoint blockade in patients with metastatic melanoma (MM) in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-12 Next generation sequencing of exceptional responders with BRAF-mutant melanoma: implications for sensitivity and resistance in BMC CANCER
  • 2015-12 Modification of BTLA signaling motifs in TIL exhibits positive signals that mediate anti-tumor control in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-12 Prognostic and biologic significance of high LCK expression in ovarian cancer in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-03 Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis in NATURE CELL BIOLOGY
  • 2015-02 Beyond BRAFV600: Clinical Mutation Panel Testing by Next-Generation Sequencing in Advanced Melanoma in JOURNAL OF INVESTIGATIVE DERMATOLOGY
  • 2015 Clinical Success of Adoptive Cell Transfer Therapy Using Tumor Infiltrating Lymphocytes in DEVELOPMENTS IN T CELL BASED CANCER IMMUNOTHERAPIES
  • 2014-12 Induction of systemic anti-melanoma immunity through intratumoral TLR-7/8 activation in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2014-12 Predictive immune biomarker signatures in the tumor microenvironment of melanoma metastases associated with tumor-infiltrating lymphocyte (TIL) therapy in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2014-10 Tumor-Infiltrating Lymphocyte Therapy for Melanoma: Rationale and Issues for Further Clinical Development in BIODRUGS
  • 2013-11 Immediate triggering of 4-1BB co-stimulation during initiation of tumor-infiltrating lymphocyte (TIL) expansion from melanoma tumors accelerates CD8+ T-cell outgrowth and tumor specificity in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2013-11 Development of novel combinations of targeted and immunotherapies by understanding immune resistance using a high throughput assay of T cell mediated cytotoxicity in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2013-11 The role of transcription factor Runx2 in tumor infiltrating T cells in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2013-11 IL-2 analogues: novel agents circumventing the expansion of T regulatory cells while promoting NK cell activation during IL-2 therapy in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2013-11 Identification of predictive biomarker signatures in melanoma tumors associated with response to tumor-infiltrating lymphocyte (TIL) therapy in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2013-11 Genetically modified artificial antigen-presenting cells (aAPC) for expansion of melanoma tumor infiltrating lymphocytes with optimal properties for adoptive cell therapy in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2013-11 Uncovering a novel function of BTLA on tumor-infiltrating CD8+ T cells in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2013-04 Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion in NATURE MEDICINE
  • 2012-12 Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2012-10 Comparison of two dosing schedules of palonosetron for the prevention of nausea and vomiting due to interleukin-2-based biochemotherapy in SUPPORTIVE CARE IN CANCER
  • 2012 Adoptive Cell Therapy for the Treatment of Metastatic Melanoma in TARGETED THERAPEUTICS IN MELANOMA
  • 2011-12 The iSBTc/SITC primer on tumor immunology and biological therapy of cancer: a summary of the 2010 program in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2011-10 The ubiquitin ligase Peli1 negatively regulates T cell activation and prevents autoimmunity in NATURE IMMUNOLOGY
  • 2011-04 A peptidoglycan monomer with the glutamine to serine change and basic peptides bind in silico to TLR-2 (403–455) in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2009-12 Summary of the primer on tumor immunology and the biological therapy of cancer in JOURNAL OF TRANSLATIONAL MEDICINE
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.240145.6", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417768.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.420086.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.48336.3a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.280268.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.94365.3d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.267308.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.137628.9", 
            "type": "Organization"
          }
        ], 
        "familyName": "Hwu", 
        "givenName": "Patrick", 
        "id": "sg:person.0702415721.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702415721.17"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:55", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_642.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0702415721.17'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0702415721.17'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0702415721.17'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0702415721.17'


     

    This table displays all metadata directly associated to this object as RDF triples.

    30 TRIPLES      10 PREDICATES      18 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.0702415721.17 schema:affiliation Ne5988d62028d4cd6956e591cf40b5e69
    2 https://www.grid.ac/institutes/grid.137628.9
    3 https://www.grid.ac/institutes/grid.267308.8
    4 https://www.grid.ac/institutes/grid.280268.6
    5 https://www.grid.ac/institutes/grid.417768.b
    6 https://www.grid.ac/institutes/grid.420086.8
    7 https://www.grid.ac/institutes/grid.48336.3a
    8 https://www.grid.ac/institutes/grid.94365.3d
    9 schema:familyName Hwu
    10 schema:givenName Patrick
    11 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702415721.17
    12 schema:sdDatePublished 2019-03-07T14:55
    13 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    14 schema:sdPublisher N1639e463040d4bebb28cb18c23e771a0
    15 sgo:license sg:explorer/license/
    16 sgo:sdDataset persons
    17 rdf:type schema:Person
    18 N1639e463040d4bebb28cb18c23e771a0 schema:name Springer Nature - SN SciGraph project
    19 rdf:type schema:Organization
    20 Ne5988d62028d4cd6956e591cf40b5e69 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
    21 sgo:isCurrent true
    22 rdf:type schema:OrganizationRole
    23 https://www.grid.ac/institutes/grid.137628.9 schema:Organization
    24 https://www.grid.ac/institutes/grid.240145.6 schema:Organization
    25 https://www.grid.ac/institutes/grid.267308.8 schema:Organization
    26 https://www.grid.ac/institutes/grid.280268.6 schema:Organization
    27 https://www.grid.ac/institutes/grid.417768.b schema:Organization
    28 https://www.grid.ac/institutes/grid.420086.8 schema:Organization
    29 https://www.grid.ac/institutes/grid.48336.3a schema:Organization
    30 https://www.grid.ac/institutes/grid.94365.3d schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...